View CNVs/SVs
 View by Evidence Type: All (
	CNVs Only Present In Patients  
	de novo CNVs  
	Overlapping/Recurrent CNVs  
    
                  
                        
	CNVs Overlapping With ACRD  
	CNVs Not Present In Control  
	Significant Enriched CNVs  
	Others 
	All 
)
View by Chromosome:All ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
| CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| AutCNV0005107 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Nava C, 2015 | 
| AutCNV0005108 | 8 | - | loss | 1 | 1 | CNVs Only Present In Patients; | Nava C, 2015 | 
| AutCNV0005109 | 15 | - | loss | 1 | 1 | CNVs Only Present In Patients; | Nava C, 2015 | 
| AutCNV0005110 | 1 | 1p13.3 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005111 | 1 | 1q42.2 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005112 | 3 | 3p14.2 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005113 | 6 | 6p21.32 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Kanduri C, 2016 | 
| AutCNV0005114 | 14 | 14q12 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005115 | 15 | 15q11.2 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005116 | 15 | 15q11.2 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005117 | 15 | 15q13.2q13.3 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005118 | 16 | 16p13.3 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005119 | 17 | 17q12 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Kanduri C, 2016 | 
| AutCNV0005120 | 22 | 22q11.21 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005121 | 22 | 22q11.21 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 | 
| AutCNV0005122 | 15 | 15q23q24.1 | loss | - | - | CNVs Only Present In Patients; | Siu WK, 2016 | 
| AutCNV0005123 | 7 | 7p22.3 | loss | - | - | CNVs Only Present In Patients; | Farach LS, 2016 | 
| AutCNV0005124 | 3 | 3q29 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Biamino E, 2016 | 
| AutCNV0005125 | 14 | 14q11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Stolerman ES, 2016 | 
| AutCNV0005126 | 6 | 6q26 | gain | - | - | CNVs Only Present In Patients; | Yin CL, 2016 | 
| AutCNV0005127 | 6 | 6q26 | gain | - | - | CNVs Only Present In Patients; | Yin CL, 2016 | 
| AutCNV0005128 | 6 | 6q26 | loss | - | - | CNVs Only Present In Patients; | Yin CL, 2016 | 
| AutCNV0005129 | 6 | 6q26 | loss | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Yin CL, 2016 | 
| AutCNV0005130 | 6 | 6q26 | gain | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Yin CL, 2016 | 
| AutCNV0005131 | 6 | 6q26 | loss | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Yin CL, 2016 | 

